SDS8000A系列高带宽高分辨率数字示波器，模拟通道带宽最高可达16GHz，搭载基于硬件ADC实现的 12-bit垂直分辨率，每通道实时采样率高达40GSa/s，存储深度最大2Gpts/通道，最高500,000wfm/s波形 捕获率，四通道均可实现176µVrms（Typ.）超低本底噪声。不仅能满足高速信号测量和捕捉微小信号 的需求，还提供MIPI、DDR、PCIe、以太网等一致性分析功能，搭配眼图和抖动分析工具及丰富的协 议解码，可为半导体研发、高速通信系统验证等提供全方位的解决方案。 格隆汇10月10日丨鼎阳科技(688112.SH)公布，公司正式公开发布带宽最高达16GHz、12-bit垂直分辨率 （基于硬件ADC）的SDS8000A系列高带宽高分辨率数字示波器。 本次发布的新产品属于高端系列产品，不仅体现了公司的技术创新能力和产品开发能力，更是公司产品 高端化发展战略的重要成果，是公司在数字示波器领域持续创新历程中的重要里程碑，将有助于提升公 司的核心竞争力，对公司未来的发展将产生积极的影响。 ...

智通财经APP讯，鼎阳科技(688112.SH)发布公告，2025年10月10日，公司正式公开发布带宽最高达 16GHz、12-bit垂直分辨率(基于硬件ADC)的SDS8000A系列高带宽高分辨率数字示波器。 SDS8000A系列高带宽高分辨率数字示波器，模拟通道带宽最高可达16GHz，搭载基于硬件ADC实现的 12-bit垂直分辨率，每通道实时采样率高达40GSa/s，存储深度最大2Gpts/通道，最高500,000wfm/s波形 捕获率，四通道均可实现176µVrms(Typ.)超低本底噪声。不仅能满足高速信号测量和捕捉微小信号的需 求，还提供MIPI、DDR、PCIe、以太网等一致性分析功能，搭配眼图和抖动分析工具及丰富的协议解 码，可为半导体研发、高速通信系统验证等提供全方位的解决方案。 本次发布的新产品属于高端系列产品，不仅体现了公司的技术创新能力和产品开发能力，更是公司产品 高端化发展战略的重要成果，是公司在数字示波器领域持续创新历程中的重要里程碑，将有助于提升公 司的核心竞争力，对公司未来的发展将产生积极的影响。 ...

深圳市鼎阳科技股份有限公司正式发布SDS8000A系列高带宽高分辨率数字示波器。该系列产品模拟通 道带宽最高16GHz，12 - bit垂直分辨率，每通道实时采样率40GSa/s，存储深度最大2Gpts/通道，波形捕 获率最高500,000wfm/s，四通道均能实现超低本底噪声。产品可满足多领域需求，提供全方位解决方 案。这是公司高端化战略重要成果，提升了产品性能与竞争力。不过，新产品大规模销售需经客户试用 评估，存在市场推广不及预期风险，提醒投资者注意风险、理性投资。 ...

Group 1 - Foreign institutions have shown a high frequency and broad coverage in their research of A-share listed companies, with 415 foreign institutions conducting a total of 1,885 research sessions since the second half of the year [1][2] - Key sectors of focus for foreign institutions include industrial machinery, electronic components, integrated circuits, electronic instruments, and medical care equipment, with companies like Huichuan Technology, Estun, Huaming Equipment, and Optoelectronics receiving over 80 research sessions each [1][2] - Notable foreign institutions such as Point72, Goldman Sachs, Bank of America Securities, and Citigroup have been particularly active, with Point72 leading with 63 research sessions [2] Group 2 - The current global political and economic uncertainties have increased investor interest in assets with higher certainty, with China being viewed as a stable environment amidst complex geopolitical trends [2][3] - Significant trends such as the rise of emerging consumption, strong demand for export trade, and investments related to artificial intelligence (AI) are boosting market confidence in China's economic growth prospects [3] - Foreign institutions are optimistic about the long-term growth resilience of the Chinese economy and the trend of industrial upgrading, with a focus on technology, high-end manufacturing, and healthcare sectors [6] Group 3 - The healthcare equipment sector has also attracted significant attention from foreign institutions, with companies like United Imaging, Mindray, and Aohua Endoscopy seeing high research activity due to long-term growth drivers such as aging population and increased health awareness [5] - Foreign institutions are strategically positioning themselves in sectors like technology, high-end manufacturing, and healthcare, while also exploring structural opportunities in consumption and new energy [4] - The investment outlook for Chinese stocks remains positive, particularly for companies that continuously invest in R&D and possess core technologies with international competitiveness [4][6]

Group 1 - Foreign institutions have shown high frequency and broad coverage in their research on A-share listed companies, with 415 foreign institutions conducting a total of 1,885 research sessions since the second half of the year [1][2] - Key sectors of focus for foreign institutions include industrial machinery, electronic components, integrated circuits, electronic instruments, and medical equipment, with companies like Huichuan Technology, Estun, Huaming Equipment, and Optoelectronics receiving over 80 research sessions each [1][2] - Notable foreign institutions such as Point72, Goldman Sachs, Bank of America Securities, and Citigroup have been particularly active, with Point72 leading with 63 research sessions [2] Group 2 - The current global political and economic uncertainties have increased investor interest in assets with higher certainty, with China being viewed as a stable environment with strong economic resilience [2][3] - Emerging trends such as the rise of new consumption, strong demand for export trade, and investments related to artificial intelligence (AI) are boosting market confidence in China's economic growth prospects [3] - Foreign institutions are optimistic about sectors like technology, high-end manufacturing, and healthcare, with a clear investment logic emerging in these areas [4] Group 3 - The healthcare equipment sector has also attracted significant attention from foreign institutions, driven by long-term growth factors such as an aging population and increased health awareness among residents [5] - Foreign institutions recognize the long-term growth resilience of the Chinese economy and the trend of industrial upgrading, capturing investment opportunities through in-depth research [6]

Group 1 - A total of 395 foreign institutions have participated in A-share listed company research since the beginning of the second half of the year, with a cumulative research count of 1,782 times as of September 16 [1] - Point72 has conducted the most research, with 59 instances, while Goldman Sachs, Bank of America Securities, and Citigroup have each exceeded 40 research instances [1] Group 2 - Key sectors attracting foreign institutional attention include industrial machinery, electrical equipment, electronic instruments, and medical care equipment [3] - Companies such as Estun, Huaming Equipment, Opto, Tianfu Communication, Lens Technology, United Imaging, Mindray, and BeiGene have received research from over 50 foreign institutions [3] - Estun's recent investor relations activity indicates that foreign institutions like Merrill Lynch, Citigroup, Morgan Stanley, BNP Paribas, Deutsche Bank, and Point72 are focused on the demand situation in downstream industries, with Estun expecting continued growth in automotive, electronics, and lithium battery sectors [3] - United Imaging has reported that its AI-driven smart operation system has significantly improved efficiency and reduced costs, supporting its long-term development in the global medical imaging industry [3] - Many foreign institutions believe that the A-share market currently offers rich investment opportunities, particularly in the technology and pharmaceutical sectors [3] - Morgan Stanley recently highlighted areas to watch in the A-share market, including AI computing and applications, innovative drugs, new energy (benefiting from policy adjustments), semiconductors, new consumption, resource products, and high-end manufacturing [3]

下半年以来，近400家外资机构密集调研A股上市公司，累计调研次数近1800次，释放出对中国资产持 续关注的积极信号。参与调研的外资机构不仅包括高盛、富达、贝莱德、瑞银等国际知名投行和资管公 司，还有老虎太平洋基金、Point72等知名对冲基金。 ◎记者 王彭 从调研方向来看，外资机构关注点集中在工业机械、电气设备、电子仪器、医疗保健等高端制造和科技 创新领域。 积极挖掘A股投资机会 站在当前时点，多家外资机构认为，A股市场具有丰富的投资机会，尤其是科技、医药等领域。 路博迈基金首席市场策略师朱冰倩在接受上海证券报记者采访时表示，基于技术突破情况、政策支持和 市场趋势，在硬科技的众多细分领域中，更看好半导体芯片和AI算法应用两个领域。 外资下半年以来调研近1800次 Wind数据显示，截至9月16日，下半年以来共有395家外资机构现身A股上市公司调研名单，合计调研 1782次。 具体来看，被称为"华尔街最疯狂赚钱机器"的Point72下半年以来调研A股上市公司59次，在外资机构中 排名第一；高盛、美银证券、花旗环球、路博迈等机构的调研次数也均超40次。知名对冲基金老虎太平 洋基金则调研了捷众科技、迈瑞医疗、爱博 ...

Core Viewpoint - In the 2025 semi-annual performance meeting, the company announced the launch of several new products, indicating a strong focus on innovation and product development [1] Product Launches - The company has released multiple products in 2025, including the MHO900 series ultra-portable high-resolution digital oscilloscopes, RSA6000 series real-time spectrum analyzers, and SPQ solutions [1] - Several high-end and innovative projects are currently under research and development, with plans for gradual release based on product development progress [1]

Core Viewpoint - The company has successfully developed a new generation of agile signal generators, enhancing testing capabilities in complex electronic systems [1] Group 1: Technology Breakthrough - The new signal generator features frequency/power/modulation agility covering a full frequency range from 10MHz to 44GHz [1] - It significantly improves the instantaneous response of electronic systems and the simulation testing level in wideband and large-space complex scenarios [1] Group 2: Modulation Capabilities - The device has a maximum bandwidth vector modulation capability of 2GHz, enabling it to perform various modulation tasks [1] - The combination of intrapulse modulation signals and frequency power agility makes it a valuable tool for testing scenarios related to multi-radiation source reconnaissance systems [1]

Core Viewpoint - The company has implemented a "Quality Improvement and Return to Shareholders" action plan for 2025, focusing on enhancing core competitiveness, increasing R&D investment, and ensuring shareholder returns through consistent cash dividends [1][3]. Group 1: Business Performance - The company achieved a net profit attributable to shareholders of 75.5164 million yuan in the first half of 2025, representing a year-on-year increase [1]. - R&D expenses reached 60.2216 million yuan, up 37.08% year-on-year, accounting for a growing proportion of operating income [1][2]. - The company holds 396 authorized patents, an increase of 67 patents or 20.36% year-on-year, including 246 invention patents, which grew by 30 patents or 13.89% [2]. Group 2: Product Development - New product launches in the first half of 2025 include high-end waveform generators and high-resolution digital oscilloscopes, enhancing the product matrix and performance [2]. - Specific new products include the SDG8000A waveform generator with 5 GHz and the SDS5000X HD oscilloscope with 1 GHz and 8 channels [2]. Group 3: Shareholder Returns - The company has distributed a total of 361.95 million yuan in cash dividends over the past four years, representing 73.99% of the cumulative net profit attributable to shareholders [1][3]. - In the first half of 2025, the company paid a cash dividend of 5.10 yuan per 10 shares, with a payout ratio of 72.42% of the net profit [1][3]. Group 4: Investor Communication - The company has enhanced communication with investors through various channels, including performance briefings and direct interactions with executives [3][4]. - The company is committed to maintaining a minimum cash dividend ratio of 30% of the net profit attributable to shareholders in 2025 [3]. Group 5: Corporate Governance - The company is focused on improving governance structures and decision-making processes to ensure compliance with regulatory requirements [4]. - Training sessions for key personnel have been organized to enhance awareness of market regulations and compliance [4].